State Street Corp Cytosorbents Corp Transaction History

State Street Corp

$2.36 Trillion
Q1 2025

A detailed history of State Street Corp transactions in Cytosorbents Corp stock. As of the latest transaction made, State Street Corp holds 159,293 shares of CTSO stock, worth $173,629. This represents 0.0% of its overall portfolio holdings.

Number of Shares

159,293

Previous 159,293 -0.0%

Holding current value

$173,629

Previous $143,000 11.19%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$0.74 - $1.35 $14,060 - $25,650	19,000 Added 13.54%	159,293 $143,000
Q1 2024 May 15, 2024	SELL	$0.86 - $1.07 $9,288 - $11,556	-10,800 Reduced 7.15%	140,293 $133,000
Q2 2023 Aug 14, 2023	SELL	$2.37 - $3.65 $2,133 - $3,285	-900 Reduced 0.59%	151,093 $542,000
Q4 2022 Feb 14, 2023	SELL	$1.03 - $2.03 $5,768 - $11,367	-5,600 Reduced 3.55%	151,993 $235,000
Q2 2022 Aug 15, 2022	SELL	$1.76 - $3.22 $994,568 - $1.82 Million	-565,096 Reduced 78.19%	157,593 $345,000
Q1 2022 May 16, 2022	BUY	$2.88 - $4.23 $5,474 - $8,041	1,901 Added 0.26%	722,689 $2.31 Million
Q4 2021 Feb 14, 2022	SELL	$4.05 - $8.11 $4,774 - $9,561	-1,179 Reduced 0.16%	720,788 $3.02 Million
Q3 2021 Nov 15, 2021	BUY	$7.0 - $9.71 $52,899 - $73,378	7,557 Added 1.06%	721,967 $5.86 Million
Q2 2021 Aug 16, 2021	BUY	$7.55 - $9.42 $427,511 - $533,398	56,624 Added 8.61%	714,410 $5.39 Million
Q1 2021 May 17, 2021	BUY	$8.23 - $11.48 $110,084 - $153,556	13,376 Added 2.08%	657,786 $5.71 Million
Q4 2020 Feb 16, 2021	BUY	$7.65 - $8.98 $238,527 - $279,996	31,180 Added 5.08%	644,410 $5.14 Million
Q3 2020 Nov 10, 2020	BUY	$7.37 - $11.54 $395,164 - $618,751	53,618 Added 9.58%	613,230 $4.89 Million
Q2 2020 Aug 14, 2020	BUY	$6.28 - $10.59 $128,928 - $217,412	20,530 Added 3.81%	559,612 $5.54 Million
Q1 2020 May 11, 2020	BUY	$3.77 - $7.73 $2.03 Million - $4.17 Million	539,082 New	539,082 $4.17 Million

Others Institutions Holding CTSO

# of Institutions

Shares Held

17.2M

Call Options Held

8.1K

Put Options Held

6.9K

View Full List

About Cytosorbents Corp

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $47.5M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

More about CTSO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Cytosorbents Corp Transaction History